Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 10:28 PM
Study NCT ID:
NCT04337658
Status:
NOT_YET_RECRUITING
Last Update Posted:
2020-04-08
First Post:
2020-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-11
First Submit QC Date:
None
Study First Post Date:
2020-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-05
Last Update Post Date:
2020-04-08
Last Update Post Date Type:
ACTUAL